OpenURL Connection Search

Select item for more details and to access through your institution.

Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice T.M. Camp et al.: MMP-9 induces apoptosis.
Published in:
Diabetologia, 2003, v. 46, n. 10, p. 1438, doi. 10.1007/s00125-003-1200-y
By:
- Camp, T. M.;
- Tyagi, S. C.;
- Senior, R. M.;
- Hayden, M. R.
Publication type:
Article
GECKOS: Turning galaxy evolution on its side with deep observations of edge-on galaxies.
Published in:
Proceedings of the International Astronomical Union, 2022, v. 18, n. S377, p. 27, doi. 10.1017/S1743921323001138
By:
- van de Sande, J.;
- Fraser-McKelvie, A.;
- Fisher, D. B.;
- Martig, M.;
- Hayden, M. R.
Publication type:
Article
Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans.
Published in:
Clinical Genetics, 2011, v. 79, n. 6, p. 575, doi. 10.1111/j.1399-0004.2011.01682.x
By:
- Brunham, L. R.;
- Tietjen, I.;
- Bochem, A. E.;
- Singaraja, R. R.;
- Franchini, P. L.;
- Radomski, C.;
- Mattice, M.;
- Legendre, A.;
- Hovingh, G. K.;
- Kastelein, J. J. P.;
- Hayden, M. R.
Publication type:
Article
Managing genetic discrimination: Strategies used by individuals found to have the Huntington disease mutation.
Published in:
Clinical Genetics, 2007, v. 71, n. 3, p. 220, doi. 10.1111/j.1399-0004.2007.00770.x
By:
- Bombard, Y.;
- Penziner, E.;
- Decolongon, J.;
- Klimek, M. L. N.;
- Creighton, S.;
- Suchowersky, O.;
- Guttman, M.;
- Paulsen, J. S.;
- Bottorff, J. L.;
- Hayden, M. R.
Publication type:
Article
Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.
Published in:
Clinical Genetics, 2006, v. 70, n. 4, p. 283, doi. 10.1111/j.1399-0004.2006.00668.x
By:
- Semaka, A.;
- Creighton, S.;
- Warby, S.;
- Hayden, M. R.
Publication type:
Article
Pharmacogenomic diversity in Singaporean populations and Europeans.
Published in:
Pharmacogenomics Journal, 2014, v. 14, n. 6, p. 555, doi. 10.1038/tpj.2014.22
By:
- Brunham, L R;
- Chan, S L;
- Li, R;
- Aminkeng, F;
- Liu, X;
- Saw, W Y;
- Ong, R T H;
- Pillai, E N;
- Carleton, B C;
- Toh, D;
- Tan, S H;
- Koo, S H;
- Lee, E J D;
- Chia, K S;
- Ross, C J D;
- Hayden, M R;
- Sung, C;
- Teo, Y Y
Publication type:
Article
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.
Published in:
Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 160, doi. 10.1038/tpj.2013.13
By:
- Aminkeng, F;
- Ross, C J D;
- Rassekh, S R;
- Brunham, L R;
- Sistonen, J;
- Dube, M-P;
- Ibrahim, M;
- Nyambo, T B;
- Omar, S A;
- Froment, A;
- Bodo, J-M;
- Tishkoff, S;
- Carleton, B C;
- Hayden, M R
Publication type:
Article
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Published in:
Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 233, doi. 10.1038/tpj.2010.92
By:
- Brunham, L R;
- Lansberg, P J;
- Zhang, L;
- Miao, F;
- Carter, C;
- Hovingh, G K;
- Visscher, H;
- Jukema, J W;
- Stalenhoef, A F;
- Ross, C J D;
- Carleton, B C;
- Kastelein, J J P;
- Hayden, M R
Publication type:
Article
Application of principal component analysis to pharmacogenomic studies in Canada.
Published in:
Pharmacogenomics Journal, 2009, v. 9, n. 6, p. 362, doi. 10.1038/tpj.2009.36
By:
- Visscher, H.;
- Ross, C. J. D.;
- Dubé, M. -P.;
- Brown, A. M. K.;
- Phillips, M. S.;
- Carleton, B. C.;
- Hayden, M. R.
Publication type:
Article
Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits.
Published in:
Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 6, p. 792, doi. 10.1038/clpt.2010.125
By:
- Madadi, P.;
- Joly, Y.;
- Avard, D.;
- Chitayat, D. C.;
- Smith, M. A.;
- Ross, C. J. D.;
- Carleton, B. C.;
- Hayden, M. R.;
- Koren, G.
Publication type:
Article
Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 1, p. 31, doi. 10.1038/clpt.2008.157
By:
- Madadi, P.;
- Ross, C. J. D.;
- Hayden, M. R.;
- Carleton, B. C.;
- Gaedigk, A.;
- Leeder, J. S.;
- Koren, G.
Publication type:
Article
The FDG/PET Methodology for Early Detection of Disease Onset: A Statistical Model.
Published in:
Journal of Cerebral Blood Flow & Metabolism, 1991, v. 11, p. A96, doi. 10.1038/jcbfm.1991.44
By:
- Clark, C. M.;
- Ammann, W.;
- Martin, W. R. W.;
- Ty, P.;
- Hayden, M. R.
Publication type:
Article
Regression Model for Predicting Dissociations of Regional Cerebral Glucose Metabolism in Individuals at Risk for Huntington's Disease.
Published in:
Journal of Cerebral Blood Flow & Metabolism, 1986, v. 6, n. 6, p. 756, doi. 10.1038/jcbfm.1986.132
By:
- Clark, C. M.;
- Hayden, M. R.;
- Stoessl, A. J.;
- Martin, W. R. W.
Publication type:
Article
HDL deficiency and atherosclerosis: lessons from Tangier disease.
Published in:
2004
By:
- Hovingh GK;
- Kuivenhoven JA;
- Bisoendial RJ;
- Groen AK;
- van Dam M;
- van Tol A;
- Wellington C;
- Hayden MR;
- Smelt AHM;
- Kastelein JJP;
- Hovingh, G K;
- Kuivenhoven, J A;
- Bisoendial, R J;
- Groen, A K;
- van Dam, M;
- van Tol, A;
- Wellington, C;
- Hayden, M R;
- Smelt, A H M;
- Kastelein, J J P
Publication type:
Case Study
Genetic analysis of potassium use efficiency in Brassica oleracea.
Published in:
Annals of Botany, 2010, v. 105, n. 7, p. 1199, doi. 10.1093/aob/mcp253
By:
- White, P. J.;
- Hammond, J. P.;
- King, G. J.;
- Bowen, H. C.;
- Hayden, R. M.;
- Meacham, M. C.;
- Spracklen, W. P.;
- Broadley, M. R.
Publication type:
Article
Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6.
Published in:
Cell Death & Differentiation, 2013, v. 20, n. 1, p. 86, doi. 10.1038/cdd.2012.98
By:
- van Raam, B J;
- Ehrnhoefer, D E;
- Hayden, M R;
- Salvesen, G S
Publication type:
Article
The Gaia-ESO Survey: Churning through the Milky Way.
Published in:
Astronomy & Astrophysics / Astronomie et Astrophysique, 2018, v. 609, p. 1, doi. 10.1051/0004-6361/201730412
By:
- Hayden, M. R.;
- Recio-Blanco, A.;
- de Laverny, P.;
- Mikolaitis, S.;
- Guiglion, G.;
- Hill, V.;
- Gilmore, G.;
- Randich, S.;
- Bayo, A.;
- Bensby, T.;
- Bergemann, M.;
- Bragaglia, A.;
- Casey, A.;
- Costado, M.;
- Feltzing, S.;
- Franciosini, E.;
- Hourihane, A.;
- Jofre, P.;
- Koposov, S.;
- Kordopatis, G.
Publication type:
Article
Mycophenolate mofetil and animal models.
Published in:
Lupus, 2006, v. 15, n. 11S, p. 27, doi. 10.1177/0961203306071675
By:
- Gibson, W T;
- Hayden, M R
Publication type:
Article
Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?
Published in:
Lupus, 2006, v. 15, n. 11S, p. 11, doi. 10.1177/0961203306071670
By:
- van Leuven, S I;
- Kastelein, J J P;
- Hayden, M R;
- Stroes, E S
Publication type:
Article
Mycophenolate mofetil and animal models.
Published in:
Lupus, 2006, v. 15, n. 1S, p. 27, doi. 10.1177/0961203306071675
By:
- Gibson, W T;
- Hayden, M R
Publication type:
Article
Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?
Published in:
Lupus, 2006, v. 15, n. 1S, p. 11, doi. 10.1177/0961203306071670
By:
- van Leuven, S I;
- Kastelein, J J P;
- Hayden, M R;
- Stroes, E S
Publication type:
Article
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
Published in:
1993
By:
- Babul R;
- Adam S;
- Kremer B;
- Dufrasne S;
- Wiggins S;
- Huggins M;
- Theilmann J;
- Bloch M;
- Hayden MR;
- Babul, R;
- Adam, S;
- Kremer, B;
- Dufrasne, S;
- Wiggins, S;
- Huggins, M;
- Theilmann, J;
- Bloch, M;
- Hayden, M R
Publication type:
journal article
Response to 'Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity'.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 2, p. 158, doi. 10.1038/clpt.2014.90
By:
- Carleton, B C;
- Ross, C J;
- Bhavsar, A P;
- Lee, J W;
- Visscher, H;
- Rassekh, S R;
- Hayden, M R
Publication type:
Article
Genetic Markers of Cisplatin-Induced Hearing Loss in Children.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 3, p. 296, doi. 10.1038/clpt.2014.92
By:
- Carleton, B C;
- Ross, C J;
- Pussegoda, K;
- Bhavsar, A P;
- Visscher, H;
- Lee, J W;
- Brooks, B;
- Rassekh, S R;
- Dubé, M‐P P;
- Hayden, M R
Publication type:
Article
Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 3, p. 253, doi. 10.1038/clpt.2013.219
By:
- Carleton, B C;
- Ross, C J;
- Bhavsar, A P;
- Amstutz, U;
- Pussegoda, K;
- Visscher, H;
- Lee, J W;
- Brooks, B;
- Rassekh, S R;
- Dubé, M‐P;
- Hayden, M R
Publication type:
Article
Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children.
Published in:
Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 2, p. 243, doi. 10.1038/clpt.2013.80
By:
- Pussegoda, K;
- Ross, C J;
- Visscher, H;
- Yazdanpanah, M;
- Brooks, B;
- Rassekh, S R;
- Zada, Y F;
- Dubé, M‐P;
- Carleton, B C;
- Hayden, M R
Publication type:
Article
HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children.
Published in:
Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 1, p. 142, doi. 10.1038/clpt.2013.55
By:
- Amstutz, U;
- Ross, C J D;
- Castro‐Pastrana, L I;
- Rieder, M J;
- Shear, N H;
- Hayden, M R;
- Carleton, B C
Publication type:
Article
Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 4, p. 692, doi. 10.1038/clpt.2011.280
By:
- Sistonen, J;
- Madadi, P;
- Ross, C J;
- Yazdanpanah, M;
- Lee, J W;
- Landsmeer, M L A;
- Nauta, M;
- Carleton, B C;
- Koren, G;
- Hayden, M R
Publication type:
Article
Mens Sana in Corpore Sano.
Published in:
Journal of Sport Psychology, 1987, v. 9, n. 1, p. 3
By:
- Hayden, R. M.;
- Allen, G. J.;
- Cammaione, D. N.
Publication type:
Article
Chemical abundance gradients from open clusters in the Milky Way disk: Results from the APOGEE survey.
Published in:
Astronomische Nachrichten, 2016, v. 337, n. 8/9, p. 922, doi. 10.1002/asna.201612398
By:
- Cunha, K.;
- Frinchaboy, P.M.;
- Souto, D.;
- Thompson, B.;
- Zasowski, G.;
- Allende Prieto, C.;
- Carrera, R.;
- Chiappini, C.;
- Donor, J.;
- García-Hernández, A.;
- García Pérez, A. E.;
- Hayden, M. R.;
- Holtzman, J.;
- Jackson, K. M.;
- Johnson, J. A.;
- Majewski, S. R.;
- Mészáros, S.;
- Meyer, B.;
- Nidever, D. L.;
- O'Connell, J.
Publication type:
Article
The role of free fatty acids, pancreatic lipase and Ca<sup>2+</sup> signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice.
Published in:
Acta Physiologica, 2009, v. 195, n. 1, p. 13, doi. 10.1111/j.1748-1716.2008.01933.x
By:
- Yang, F.;
- Wang, Y.;
- Sternfeld, L.;
- Rodriguez, J. A.;
- Ross, C.;
- Hayden, M. R.;
- Carriere, F.;
- Liu, G.;
- Schulz, I.
Publication type:
Article
Contribution of DNA Sequence and CAG Size to Mutation Frequencies of Intermediate Alleles for Huntington Disease: Evidence from Single Sperm Analyses.
Published in:
Human Molecular Genetics, 1997, v. 6, n. 2, p. 301, doi. 10.1093/hmg/6.2.301
By:
- Chong, S. S.;
- Almqvist, E.;
- Telenius, H.;
- LaTray, L.;
- Nichol, K.;
- Bourdelat-Parks, B.;
- Goldberg, Y. P.;
- Haddad, B. R.;
- Richards, F.;
- Sillence, D.;
- Greenberg, C. R.;
- Ives, E.;
- Van den Engh, G.;
- Hughes, M. R.;
- Hayden, M. R.
Publication type:
Article
Absence of Disease Phenotype and Intergenerational Stability of the Cag Repeat in Transgenic Mice Expressing the Human Huntington Disease Transcript.
Published in:
Human Molecular Genetics, 1996, v. 5, n. 2, p. 177, doi. 10.1093/hmg/5.2.177
By:
- Goldberg, Y. P.;
- Kalchman, M. A.;
- Metzler, M.;
- Nasir, J.;
- Zeisler, J.;
- Graham, R.;
- Koide, H. B.;
- O'Kusky, J.;
- Sharp, A. H.;
- Ross, C. A.;
- Jirik, F.;
- Hayden, M. R.
Publication type:
Article
Detection of the Pro.
Published in:
Clinical Genetics, 1992, v. 42, n. 6, p. 273, doi. 10.1111/j.1399-0004.1992.tb03256.x
By:
- Defesche, J. C.;
- Ree, M. A.;
- Kastelein, J. J. P.;
- Diermen, D. E.;
- Janssans, N. W. E.;
- Doormaal, J. J.;
- Hayden, M. R.
Publication type:
Article
Detection of the Pro.
Published in:
Clinical Genetics, 1992, v. 42, n. 5, p. 273, doi. 10.1111/j.1399-0004.1992.tb03255.x
By:
- Defesche, J. C.;
- Ree, M. A.;
- Kastelein, J. J. P.;
- Diermen, D. E.;
- Janssens, N. W. E.;
- Doormaal, J. J.;
- Hayden, M. R.
Publication type:
Article
Age of onset in siblings of persons with juvenile Huntinqton disease.
Published in:
Clinical Genetics, 1985, v. 28, n. 2, p. 100, doi. 10.1111/j.1399-0004.1985.tb00367.x
By:
- Hayden, M. R.;
- Soles, J. A.;
- Ward, D R. H.
Publication type:
Article

Found: 36

Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice T.M. Camp et al.: MMP-9 induces apoptosis.

GECKOS: Turning galaxy evolution on its side with deep observations of edge-on galaxies.

Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans.

Managing genetic discrimination: Strategies used by individuals found to have the Huntington disease mutation.

Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.

Pharmacogenomic diversity in Singaporean populations and Europeans.

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

Application of principal component analysis to pharmacogenomic studies in Canada.

Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits.

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study.

The FDG/PET Methodology for Early Detection of Disease Onset: A Statistical Model.

Regression Model for Predicting Dissociations of Regional Cerebral Glucose Metabolism in Individuals at Risk for Huntington's Disease.

HDL deficiency and atherosclerosis: lessons from Tangier disease.

Genetic analysis of potassium use efficiency in Brassica oleracea.

Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6.

The Gaia-ESO Survey: Churning through the Milky Way.

Mycophenolate mofetil and animal models.

Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?

Mycophenolate mofetil and animal models.

Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?

Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.

Response to 'Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity'.

Genetic Markers of Cisplatin-Induced Hearing Loss in Children.

Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity.

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children.

HLA-A31:01 and HLA-B15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children.

Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers.

Mens Sana in Corpore Sano.

Chemical abundance gradients from open clusters in the Milky Way disk: Results from the APOGEE survey.

The role of free fatty acids, pancreatic lipase and Ca<sup>2+</sup> signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice.

Contribution of DNA Sequence and CAG Size to Mutation Frequencies of Intermediate Alleles for Huntington Disease: Evidence from Single Sperm Analyses.

Absence of Disease Phenotype and Intergenerational Stability of the Cag Repeat in Transgenic Mice Expressing the Human Huntington Disease Transcript.

Detection of the Pro.

Detection of the Pro.

Age of onset in siblings of persons with juvenile Huntinqton disease.